a boy with optic glioma
TRANSCRIPT
Clin Pediatr Endocrinol 1994;3(Suppl 4): 169-173Copyright(C)1994 by The Japanese Society for Pediatric Endocrinology
A Boy with Optic Glioma
Taisuke Okada, Sumitaka Dohno, Yousei Shimasaki, Takashi Tomoda, Makiko Koga,Kumiko Araki and Takanobu Kurashige
Department of Pediatrics, Kochi Medical School, Kohasu, Oko-cho, Nankoku-city, Kochi, Japan
Abstract. A 6-month-old boy had nystagmus. Hydrocephalus and a large hypothalamic tumor
were found by MRI. After partial resection of the tumor, diabetes insipidus (DI) and ACTH
deficiency had developed. The tumor was diagnosed as optic astrocytoma, histologically.
Although he had been treated with dexamethasone, DI was not well controlled. At 1.5 years old,
he was admitted to our hospital with polyuria, obesity and hypertrichosis. The growth chart
showed that he had grown rapidly from birth. The serum level of GH was normal, but insulin like
growth factor (IGF)-I value was high. Serum levels of insulin and prolactin were normal. Ontreatment with low doses of hydrocortisone and DDAVP, the urine volume and serum level of
IGF-I decreased. He was diagnosed as having partial GH deficiency by intravenous insulin
stimulation test. He has blindness and slight mental retardation now. The etiology of his
overgrowth is not known clearly, but some other unknown growth factor may have stimulated
his growth.
Key words: optic glioma, overgrowth, diabetes insipidus, ACTH deficiency, IGF- I
Introduction
Gliomas of the optic nerve and chiasm arerare, and occur most commonly in childhood.
The majority of these tumors are low-grade
astrocytomas histologically, but the clinicalcourse of these tumors is not benign. Tumorsinvolving the optic chiasm and particularly
extending outside of the chiasm into thehypothalamus tend to be more aggressive
than tumors involving the optic nerve alone
(1). Chiasmatic-hypothalamic gliomas oftencause endocrine abnormalities in addition tovisual symptoms and have been associated
with the diencephalic syndrome of emaciation
(2). We report here a case of optic glioma inwhom overgrowth in both height and weight
developed from birth.
Case Report
The patient had a normal, full-term, spon-
taneous delivery. The growth chart showed
that he had grown rapidly from birth. He was
first noted to have macrocephaly and slightly
retarded head control at the age of 4 months.
Correspondence: Dr. Taisuke Okada, Department of Pediatrics,
Kochi Medical School, Kohasu, Oko-cho, Nankoku-shi, Kochi783 Japan
169
170
OKADA et al.
Fig. 1. Magnetic resonance T1-weighted image, coronalprojection, obtained after administration ofgadolinium. Note the enhancing mass in thesupra- sellar area.
He was admitted to another hospital because of nystagmus at the age of 6 months. Hydroce-phalus and hypothalamic tumor were foundby MRI and he was referred to our hospital foroperation. MRI on admission (Fig. 1) showeda 5cm diameter suprasellar tumor which wasenhanced homogenously by administration ofgadlinium. The V-P shunt operation and par-tial resection of the tumor were performed;thereafter, diabetes insipidus (DI) and ACTHdeficiency appeared. The diagnosis ofastrocytoma was made histologically.Although he had been treated with dex-amethasone and 1-deamino-8-D-arginine vaso-pression (DDAVP) or indomethacin, DI wasnot well controlled. At age 16 months he wasreadmitted to our hospital with polyuria, obe-sity, and hypertrichosis. On admission, hisheight was 84cm (+ 2.0SD), weight 15.0kg (+3.5SD) and his head circumference was 55cm(+3.8SD) (Fig. 2). Bone age was slightlyretarded. The urine volume was about 3liters/day and the specific gravity was 1.003.Serum osmolarity was 298mOsm/kg, urine
Fig. 2. Growth Chart
osmolarity was 171mOsm/kg, and antidiuretic
hormone (ADH) was 0.8pg/ml. The level of
growth hormone (GH) was normal, but IGF-I
value was high. Urinary GH secretion was not
detected. Serum prolactin level and TSH were
within normal limits. ACTH and cortisol
levels were low (Table. 1). With administra-
tion of hydrocortisone (30mg/day) and
DDAVP (1.3pg twice a day), urine volume and
serum IGF-I level gradually decreased. At age
19 months, the dosage of hydrocortisone and
DDAVP was 17mg/day and 2.5ƒÊg twice a day
respectively. The urine volume was about 1.2
liters/day and serum values of ACTH and
cortisol were low (Fig. 3). Serum insulin value
was normal, but serum prolactin level slightly
increased. ACTH, cortisol, and GH showed
low responses to hypoglycemia by intravenous
insulin stimulation test (0.05U/kg). Rapid
ACTH test revealed low adrenal function
(Tabled). Therefore, he was diagnosed as
having partial GH deficiency. However, his
171
A Boy with Optic Glioma
Table 1. Laboratory Data (1993, May)
overgrowth has continued in both height andweight. He has blindness and slight mental
retardation. The optic glioma has not shownregrowth as followed by MRI examination,
without chemotherapy or radiotherapy (Fig.4).
Discussion
Optic pathway/hypothalamic astrocytomasin childhood have long been believed to followa highly unpredictable course (3). Someremain static for many years, while othersincrease in size and can lead to significantmorbidity and even to death. Observationonly, or treatments by radiotherapy, chemo-therapy, and surgical resection have all beenproposed. Consequently, there is no uniformmethod of management. In this case, the largetumor was placed posteriorly, resulting inhydrocephalus and endocrinological dysfunc-tion without neurofibromatosis. Harold et al.say that anteriorly placed tumors restricted toone orbit and causing unsightly proptosis andsignificant visual loss had better be resected(3). Posteriorly placed tumors causinghydrocephalus and/or endocrinological
Fig. 3. Clinical Course
Fig. 4. No evidence of tumor regrowth compared to
preoperation.
dysfunction are treated with shunting andresection, with medical therapy for the endo-crinological dysfunction. As these posteriorlyplaced optic pathway tumors cannot, how-ever, undergo total surgical excision, radiationtherapy and/or chemotherapy may be needed.Radiation therapy is sure to be effective inpatients with optic glioma with involvement
172
OKADA et al.
of the chiasm and posterior structures (4)(5),
but the side effects of irradiation can be seri-ous (6), so chemotherapy should be consideredin the initial management following resection
(7). In our patient the symptoms did notprogress on clinical and radiographic evalua-tion without chemotherapy and radiationtherapy. He has to be followed carefully byMRI and further treatment may be needed if
the tumor should progress.Clinical manifestations of optic glioma
may be decreased vision, headache or endo-
crine dysfunction. A variety of endocrinedysfunctions are reported such as precocious
puberty, GH deficiency, delayed puberty, DI,hypothyroidism, and hypopituitarism. Our
case had DI, ACTH deficiency, and probably
partial GH deficiency. However, he had over-
growth from birth. Overgrowth in patientswith optic glioma has not previously beenreported, to our knowledge. The etiology ofthis overgrowth is unknown. Overgrowth
already developed before administration ofhydrocortisone and contined during therapy.As he had partial GH deficiency, it was sug-
gested that some growth factor, which wassecreted by the tumor, might have acceleratedhis growth from birth. The level of IGF-I washigh in spite of GH deficiency, but it de-.
creased by reducing the dose of hydrocor-tisone. Therefore, administration of hydrocor-
tisone was thought to induce the high level ofIGF-I. Although IGF-I producing astrocytomahas been reported (8), there is no report of
optic glioma that produced some growth fac-tor. On the other hand, it has been reported
that some patients with brain tumor hadnormal or accelerated growth in spite of GH
deficiency (9). The mechanisms of the growthin these cases have not been clarified. These
patients had hyperphagia and severe obesity.A high level of serum insulin or hyper-
prolactinemia can be associated with a normalIGF-I value in GH deficient patients. In our
case, the serum value of insulin was normal,but prolactin was at a slightly high level. As
overgrowth appeared when the serum
prolactin level was normal, prolactin might
have no direct relation to his overgrowth.
Therefore, some other growth factor secreted
by the tumor may have acted as a stimulating
factor. We must evaluate the bioactivity of
IGF-I to clarify the mechanism of his over-
growth.
Conclusion
1. We have reported here a case of optic
glioma who had DI, ACTH deficiency,
partial GH deficiency and overgrowth.2. DI and ACTH deficiency was well
controlled by replacement therapy, but the
etiology of overgrowth has not been deter-
mined. Some other unknown growth factor
may act as a stimulating factor.
3. 8 months after operation, the residual
tumor had not regrown by MRI and he was
watched, without chemotherapy or radio-
therapy. If the tumor progresses further
treatment may be needed.
References
1. John CF, Carlos T, Melvin D. Managementof low-grade gliomas of the optic nerve andchiasm. Cancer 1988; 61: 635-42.
2. Luis AR, Michael SBE, Victor AL. Man-agement of hypothalamic gliomas in chil-dren: an analysis of 33 cases. Neurosurgery1990; 26: 242-7.
3. Harold JH, Robin PH, James MD, LaurenceEB, Derek J, et al. Optic pathway/hypoth-alamic gliomas: a dilemma in manage-ment. Pediatr Neurosurg 1993; 186-95.
4. Bataini JP, Delanian S, Ponvert D. Chias-mal gliomas: results of irradiation manage-ment in 57 patients and review of litera-ture. Int J Radiation Oncology Biol Phys1991; 21: 615-23.
5. Susan MP, Patrick DB, Jay SL, CorneliusM, Nancy JT. Definitive radiation therapyin the management of symptomaticpatients with optic glioma. Cencer 1990; 65:45-52.
173
A Boy with Optic Glioma
6. Leena W, Robert HS, Gerald AK, Chung
TC, Ronald LD. Controversy in the man-
agement of optic nerve glioma. Cancer
1987; 59: 1000-4.
7. Amar G, Richard LH, Edward HK, James
AL, Robert AS, et al. Response of
pediatric low grade gliomas to chemother-apy. Pediatr Neurosurg 1993; 19: 113-20.
8. Walter Z, Maria S, Tiit R. Insulin-like
growth factor (IGF)-I, and II and IGF-binding proteins in the cyst fluid of a
patient with astrocytoma. 1993; 9: 100-3.9. Thomsett MJ, Conte FA, Kaplan SL,
Grumbach MM. Endocrine and neurologicoutcome in childhood craniopharyngioma.
J Pediatr 1980; 97: 728-35.